Breaking News Instant updates and real-time market news.

NBLX

Noble Midstream

$37.70

-1.28 (-3.28%)

17:04
10/02/18
10/02
17:04
10/02/18
17:04

Noble Midstream provides update, in pact with with Salt Creek Midstream for JV

Noble Midstream Partners provided a commercial and business development update for its operations in the Permian Basin in Texas. Highlights include: Noble Midstream has entered into a letter of intent with Salt Creek Midstream to form a 50/50 joint venture on a crude oil pipeline and gathering system in the Delaware Basin. The Joint Venture will be underpinned by acreage contributions from Noble Midstream and Salt Creek of approximately 180,000 dedicated acres from Noble Energy and five other Southern Delaware Basin producers, with a line of sight to additional dedications totaling approximately 100,000 acres Reached long-term agreement for the Advantage Pipeline system to service a major producing company's facilities on such customer's Southern Delaware position totaling approximately 20,000 net acres. First flow is expected to commence in October 2018.Noble Midstream connected its first Delaware Basin well for a third-party producer during September. "Since our IPO, we have continued to expand our Permian service offerings beyond infield gathering and have materially enhanced our third-party platform," stated Terry R. Gerhart, Chief Executive Officer of Noble Midstream. "These opportunities build on our strategy and provide Noble Midstream additional pathways to our stated goal of 50% net EBITDA contribution from the Permian by the end of 2020."

  • 01

    Nov

NBLX Noble Midstream
$37.70

-1.28 (-3.28%)

04/11/18
MZHO
04/11/18
UPGRADE
MZHO
Buy
Noble Midstream upgraded to Buy from Neutral at Mizuho
04/19/18
DBAB
04/19/18
INITIATION
Target $57
DBAB
Buy
Noble Midstream initiated with a Buy at Deutsche Bank
Deutsche Bank started Noble Midstream Partners with a Buy rating and $57 price target.
09/24/18
WELS
09/24/18
DOWNGRADE
Target $37
WELS
Market Perform
Noble Midstream downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Praneeth Satish downgraded Noble Midstream Partners LP to Market Perform and lowered his price target for the shares to $37 from $49. The analyst steps to the sidelines citing uncertainty associated with the upcoming Colorado vote on Proposition 112. Noble Midstream has the most exposure to oil and gas production in Colorado, which represents around 80% of its EBITDA, Satish tells investors in a research note. The analyst views the vote on November 6 as a highly binary event for Noble Midstream. If Proposition 112 fails to pass, he thinks Noble Midstream is worth $49 per unit. Alternatively, if Proposition 112 passes, he thinks the company would be worth $24 per unit. Satish stresses that the energy industry is pouring considerable resources into educating voters as to the impact that reduced drilling would have on the Colorado economy. However, he believes taking a cautious approach heading into the November 6 election is prudent.
09/24/18
WELS
09/24/18
NO CHANGE
Target $45
WELS
Market Perform
Western Gas Partners price target lowered to $45 from $51 at Wells Fargo
Wells Fargo analyst Michael Blum lowered his price target for Western Gas Partners (WES) to $45 from $51, while reiterating a Market Perform rating on the shares. The analyst notes that Colorado will vote on Proposition 112 and if it passes, oil and gas development in the state could be materially impacted. Within his coverage universe, he estimates that Western Gas Partners, Noble Midstream (NBLX), NGL Energy Partners (NGL), Summit Midstream (SMLP), DCP Midstream (DCP) and SemGroup (SEMG) have the highest exposure to Colorado.

TODAY'S FREE FLY STORIES

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
EIA natural gas storage change for week ending February 15 »

Earlier, gas inventories…

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
Crude inventories for week of February 15 »

Crude oil inventories…

KR

Kroger

$28.82

0.07 (0.24%)

11:00
02/21/19
02/21
11:00
02/21/19
11:00
Options
One-day call buyers in Kroger »

One-day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 07

    Mar

UAA

Under Armour

$21.26

-0.02 (-0.09%)

, UA

Under Armour

$19.22

0.025 (0.13%)

10:52
02/21/19
02/21
10:52
02/21/19
10:52
Periodicals
Under Armour CEO questioned by board about ties with MSNBC anchor, WSJ says »

A number of current and…

UAA

Under Armour

$21.26

-0.02 (-0.09%)

UA

Under Armour

$19.22

0.025 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

10:50
02/21/19
02/21
10:50
02/21/19
10:50
General news
U.S. corporate bond update: issuance continues apace today »

U.S. corporate bond…

COUP

Coupa Software

$92.39

-1.36 (-1.45%)

10:50
02/21/19
02/21
10:50
02/21/19
10:50
Options
Short-term hedge opened in Coupa Software »

Short-term hedge opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

10:50
02/21/19
02/21
10:50
02/21/19
10:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

OHRP

Ohr Pharmaceutical

$2.01

(0.00%)

10:47
02/21/19
02/21
10:47
02/21/19
10:47
Hot Stocks
Ohr Pharmaceutical regains compliance with Nasdaq listing requirements »

Ohr Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$5.81

4.385 (307.72%)

, MRK

Merck

$79.79

0.35 (0.44%)

10:46
02/21/19
02/21
10:46
02/21/19
10:46
Downgrade
Immune Design, Merck rating change  »

Immune Design downgraded…

IMDZ

Immune Design

$5.81

4.385 (307.72%)

MRK

Merck

$79.79

0.35 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 11

    Apr

  • 18

    May

  • 17

    Jun

10:45
02/21/19
02/21
10:45
02/21/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
02/21/19
02/21
10:45
02/21/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

ANET

Arista Networks

$266.95

-3.58 (-1.32%)

10:45
02/21/19
02/21
10:45
02/21/19
10:45
Conference/Events
Arista Networks has a conference call hosted by JPMorgan »

JPMorgan Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 12

    Mar

  • 13

    Mar

  • 13

    Mar

10:45
02/21/19
02/21
10:45
02/21/19
10:45
General news
Breaking General news story  »

Week of 2/15 EIA…

NKE

Nike

$83.97

-0.87 (-1.03%)

10:40
02/21/19
02/21
10:40
02/21/19
10:40
On The Fly
Analyst sees 'minimal' lasting damage to Nike brand after Duke star's shoe splits »

Shares of Nike (NKE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFT

Weatherford

$0.79

-0.0263 (-3.21%)

10:40
02/21/19
02/21
10:40
02/21/19
10:40
Options
10.1K Weatherford Mar 1 calls trade as shares drop 2c to 80c »

10.1K Weatherford Mar 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

10:40
02/21/19
02/21
10:40
02/21/19
10:40
General news
Treasury Action: yields have cheapened despite some disappointing data »

Treasury Action: yields…

KAR

KAR Auction

$48.30

1.56 (3.34%)

10:37
02/21/19
02/21
10:37
02/21/19
10:37
Upgrade
KAR Auction rating change  »

KAR Auction upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 07

    Mar

  • 13

    Mar

  • 14

    Mar

NCLH

Norwegian Cruise Line

$55.71

1.99 (3.70%)

10:32
02/21/19
02/21
10:32
02/21/19
10:32
Recommendations
Norwegian Cruise Line analyst commentary  »

Buckingham says backdrop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 03

    Mar

  • 28

    May

BSX

Boston Scientific

$40.03

-0.1 (-0.25%)

10:30
02/21/19
02/21
10:30
02/21/19
10:30
Options
Bullish option flow in Boston Scientific »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

  • 18

    May

  • 28

    May

SNPS

Synopsys

$100.68

-2.3 (-2.23%)

10:26
02/21/19
02/21
10:26
02/21/19
10:26
Recommendations
Synopsys analyst commentary  »

Synopsys weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 03

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

NWL

Newell Brands

$17.18

0.05 (0.29%)

10:25
02/21/19
02/21
10:25
02/21/19
10:25
Periodicals
Newell Brands CEO faces board pressure following poor sales, WSJ reports »

Newell Brands CEO Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

10:25
02/21/19
02/21
10:25
02/21/19
10:25
Conference/Events
Morgan Stanley consumer goods analysts to hold analyst/industry conference call »

Executive Director of…

BIIB

Biogen

$323.78

-11.23 (-3.35%)

, ESALY

Eisai

$0.00

(0.00%)

10:25
02/21/19
02/21
10:25
02/21/19
10:25
Conference/Events
JPMorgan large-cap biotech analysts to hold an analyst/industry conference call »

Large Cap Biotech Analyst…

BIIB

Biogen

$323.78

-11.23 (-3.35%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

10:25
02/21/19
02/21
10:25
02/21/19
10:25
Conference/Events
JPMorgan retail analysts to hold an analyst/industry conference call »

Retail Analysts Boss and…

10:25
02/21/19
02/21
10:25
02/21/19
10:25
Conference/Events
Morgan Stanley sports/footwear analyst to hold analyst/industry conference call »

Sports & Footwear…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.